MedTrace Logo

Smoking Cessation for HIV/AIDS Patients

NCT00502827 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 706

Last updated 2016-02-26

No results posted yet for this study

Summary

The goal of this research study is to look at treatments that may help individuals who have HIV/AIDS to stop smoking.

Conditions

  • Human Immunodeficiency Virus

Interventions

BEHAVIORAL

Cell Phone Intervention

Study participants called on a cell phone 11 times over course of a 12 - 13 week period, during 10 minute calls questions asked about smoking and quitting smoking.

OTHER

Recommended Standard of Care

Advice from your physician to stop smoking and written materials designed to help you quit smoking.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Damon Vidrine, MS, DRPH, BA · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00502827 on ClinicalTrials.gov